GH1 and macrothrombocytopenia and granulocyte inclusions with or without nephritis or sensorineural hearing loss: Therapeutic choices for SBS patients are growth factors and seven other trophic hormones7 and among them; FDA has approved short-term application of human growth hormone, somatropin and L-glutamine in SBS patients with limited efficacy.5,8 GLP2 is an endogenous throphic peptide which has indispensable activity in improvement of intestinal growth and function.